GABA and glutamate systems as therapeutic targets in depression and mood disorders

Author： Kendell Steven F   Krystal John H   Sanacora Gerrard  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.1, 2005-02, pp. : 153-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A.   Heilig M.   Rupniak N.M.J.   Steckler T.   Griebel G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 187-206

Bentham Science Publishers

Access to resources Recommend Favorite

New Therapeutic Strategy for Mood Disorders

By  

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4284-4298

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors in the Control of Mood Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 2, 2007-04 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutic targets in bipolar mood disorder

By Soares Jair C   Sassi Roberto B  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 5, 2001-10 ,pp. : 587-599

Informa Healthcare

Access to resources Recommend Favorite